SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) accepted the company ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe ...
A new drug could let those with severe food allergies breathe a sigh of relief. Xolair, or omalizumab, was granted priority review by the Food and Drug Administration on Tuesday for its use in ...
EAST HANOVER, N.J., Aug. 13, 2020 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) accepted the company's supplemental Biologics License Application (sBLA) for a ...
The FDA is expected to make a decision by the first quarter of 2021. The Food and Drug Administration (FDA) has accepted for filing the supplemental Biologics License Application (sBLA) for a new self ...
--Novartis announced today that the US Food and Drug Administration has approved Xolair ® for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one ...
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug ...
A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. Data ...
– If approved, Xolair self-administration would offer a more flexible option to help select patients manage their treatment needs – – Filing acceptance is based on the well-established efficacy and ...
– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...
Read full article: WATCH LIVE: News 6 complete coverage of Results 2024 Read full article: 7 warnings and an advisory in effect for 5 regions in the area Select breaking news story 1 of 3 Select ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback